X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43073) 43073
Publication (2852) 2852
Book Review (562) 562
Newsletter (438) 438
Book Chapter (131) 131
Magazine Article (79) 79
Conference Proceeding (65) 65
Newspaper Article (59) 59
Book / eBook (36) 36
Dissertation (10) 10
Transcript (10) 10
Reference (8) 8
Trade Publication Article (6) 6
Government Document (4) 4
Data Set (3) 3
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33205) 33205
male (21083) 21083
female (19836) 19836
immunosuppressive agents - therapeutic use (17618) 17618
index medicus (17537) 17537
immunosuppressive agents - administration & dosage (15935) 15935
adult (13369) 13369
middle aged (12700) 12700
transplantation (11017) 11017
animals (10646) 10646
immunosuppressive agents - adverse effects (8372) 8372
treatment outcome (8218) 8218
immunology (7592) 7592
immunosuppressive agents (7290) 7290
surgery (6893) 6893
aged (6295) 6295
immunosuppressive agents - pharmacology (5584) 5584
adolescent (5169) 5169
drug therapy, combination (4882) 4882
time factors (4449) 4449
mice (4334) 4334
cyclosporine (4321) 4321
pharmacology & pharmacy (4256) 4256
therapy (4220) 4220
immunosuppression (4083) 4083
child (4080) 4080
retrospective studies (4071) 4071
kidney transplantation (3849) 3849
tacrolimus (3810) 3810
rats (3652) 3652
cyclosporine - administration & dosage (3506) 3506
risk factors (3491) 3491
follow-up studies (3482) 3482
cyclosporine - therapeutic use (3340) 3340
graft rejection - prevention & control (3116) 3116
care and treatment (3113) 3113
immunosuppressive agents - pharmacokinetics (2936) 2936
health aspects (2931) 2931
analysis (2840) 2840
tacrolimus - administration & dosage (2832) 2832
dose-response relationship, drug (2827) 2827
immunotherapy (2746) 2746
recipients (2562) 2562
drug administration schedule (2523) 2523
young adult (2518) 2518
research (2515) 2515
hematology (2451) 2451
mycophenolic acid - analogs & derivatives (2442) 2442
tacrolimus - therapeutic use (2382) 2382
drug therapy (2337) 2337
transplantation, homologous (2308) 2308
administration, oral (2294) 2294
disease (2256) 2256
medicine & public health (2251) 2251
child, preschool (2193) 2193
dosage and administration (2183) 2183
prospective studies (2170) 2170
kidneys (2152) 2152
dermatology (2117) 2117
gastroenterology & hepatology (2082) 2082
oncology (2014) 2014
rheumatology (2014) 2014
kidney transplantation - immunology (2009) 2009
urology & nephrology (1907) 1907
pharmacokinetics (1827) 1827
children (1813) 1813
recurrence (1772) 1772
medicine, general & internal (1771) 1771
pediatrics (1759) 1759
corticosteroids (1746) 1746
antibodies, monoclonal - therapeutic use (1692) 1692
sirolimus - administration & dosage (1625) 1625
inflammation (1617) 1617
immunosuppressive agents - blood (1608) 1608
cyclophosphamide (1606) 1606
efficacy (1596) 1596
mycophenolic acid - therapeutic use (1595) 1595
cyclosporine - adverse effects (1585) 1585
patients (1577) 1577
cyclophosphamide - administration & dosage (1563) 1563
prognosis (1554) 1554
liver transplantation (1553) 1553
graft survival (1528) 1528
cancer (1524) 1524
azathioprine - therapeutic use (1521) 1521
disease models, animal (1497) 1497
mycophenolate-mofetil (1494) 1494
liver (1493) 1493
diagnosis (1471) 1471
graft rejection - immunology (1468) 1468
expression (1446) 1446
biopsy (1426) 1426
rejection (1425) 1425
double-blind (1408) 1408
graft survival - drug effects (1404) 1404
azathioprine (1403) 1403
abridged index medicus (1389) 1389
calcineurin inhibitors (1386) 1386
graft rejection (1370) 1370
drugs (1368) 1368
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (27) 27
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Robarts - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (40667) 40667
German (771) 771
Japanese (620) 620
French (504) 504
Spanish (263) 263
Russian (252) 252
Chinese (180) 180
Italian (101) 101
Polish (96) 96
Hungarian (76) 76
Danish (38) 38
Czech (33) 33
Norwegian (27) 27
Portuguese (25) 25
Romanian (17) 17
Dutch (16) 16
Swedish (14) 14
Croatian (12) 12
Finnish (12) 12
Serbian (12) 12
Hebrew (10) 10
Lithuanian (9) 9
Bulgarian (8) 8
Korean (8) 8
Turkish (7) 7
Slovak (3) 3
Ukrainian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Summary Hepatitis C virus (HCV) infected patients often take multiple co-medications to treat adverse events related to HCV therapy, or to manage other... 
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | CHRONIC HEPATITIS-C | GASTROENTEROLOGY & HEPATOLOGY | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 134, Issue 7, pp. 1861 - 1868
Background & Aims: The benefit to risk ratio of concomitant immunosuppressives with scheduled infliximab (IFX) maintenance therapy for Crohn's disease is an... 
Gastroenterology and Hepatology | RHEUMATOID-ARTHRITIS | ANTIBODIES | MULTICENTER | INFLAMMATORY-BOWEL-DISEASE | THERAPY | SERUM INFLIXIMAB | LYMPHOMA | RISK | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | SHORT-TERM | Azathioprine - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Crohn Disease - metabolism | Male | Intestinal Mucosa - drug effects | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Infliximab | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Drug Therapy, Combination | France | Gastrointestinal Agents - pharmacokinetics | Immunosuppressive Agents - administration & dosage | Drug Administration Schedule | Mercaptopurine - administration & dosage | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Belgium | Antibodies, Monoclonal - administration & dosage | Crohn Disease - pathology | Crohn Disease - drug therapy | Methotrexate - administration & dosage | Gastrointestinal Agents - adverse effects | Infusions, Intravenous | Intestinal Mucosa - pathology | Clinical trials | Crohn's disease | C-reactive protein | Tumor necrosis factor | Immunotherapy | Life Sciences | Human health and pathology | Hépatology and Gastroenterology
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 10/2017, Volume 77, Issue 4, pp. 623 - 633
Journal Article
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1471 - 1481
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article